Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death

Nelly Amara, Serge Boveda, Pascal Defaye, Didier Klug, Fréderic Treguer, Denis Amet, Marie-Cécile Perier, Daniel Gras, Vincent Algalarrondo, Abdeslam Bouzeman, Olivier Piot, Jean-Claude Deharo, Laurent Fauchier, Dominique Babuty, Pierre Bordachar, Nicolas Sadoul, Eloi Marijon, Christophe Leclercq

Open source

DOI: 10.1093/europace/euw379
Published: 2017-01-11
Container: EP Europace
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/europace/euw379,
  title = {Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death},
  author = {Nelly Amara and Serge Boveda and Pascal Defaye and Didier Klug and Fréderic Treguer and Denis Amet and Marie-Cécile Perier and Daniel Gras and Vincent Algalarrondo and Abdeslam Bouzeman and Olivier Piot and Jean-Claude Deharo and Laurent Fauchier and Dominique Babuty and Pierre Bordachar and Nicolas Sadoul and Eloi Marijon and Christophe Leclercq},
  year = {2017},
  journal = {EP Europace},
  doi = {10.1093/europace/euw379},
  url = {https://doi.org/10.1093/europace/euw379}
}

RIS

TY  - JOUR
TI  - Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death
AU  - Nelly Amara
AU  - Serge Boveda
AU  - Pascal Defaye
AU  - Didier Klug
AU  - Fréderic Treguer
AU  - Denis Amet
AU  - Marie-Cécile Perier
AU  - Daniel Gras
AU  - Vincent Algalarrondo
AU  - Abdeslam Bouzeman
AU  - Olivier Piot
AU  - Jean-Claude Deharo
AU  - Laurent Fauchier
AU  - Dominique Babuty
AU  - Pierre Bordachar
AU  - Nicolas Sadoul
AU  - Eloi Marijon
AU  - Christophe Leclercq
PY  - 2017
JO  - EP Europace
DO  - 10.1093/europace/euw379
UR  - https://doi.org/10.1093/europace/euw379
ER  -

APA

Amara, N., Boveda, S., Defaye, P., Klug, D., Treguer, F., Amet, D., Perier, M., Gras, D., Algalarrondo, V., Bouzeman, A., Piot, O., Deharo, J., Fauchier, L., Babuty, D., Bordachar, P., Sadoul, N., Marijon, E., & Leclercq, C. (2017). Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death. EP Europace. https://doi.org/10.1093/europace/euw379

Source records

crossref · retrieved 2026-09-26T20:03:12.489Z